Log in
Enquire now
‌

US Patent 8252328 Bioadhesive drug formulations for oral transmucosal delivery

Patent 8252328 was granted and assigned to Acelrx Pharmaceuticals, Inc. on August, 2012 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Talphera
Talphera
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8252328
Date of Patent
August 28, 2012
Patent Application Number
11650227
Date Filed
January 5, 2007
Patent Citations Received
‌
US Patent 11672738 Apparatus and methods for dispensing oral transmucosal dosage forms
0
‌
US Patent 11676691 Storage and dispensing devices for administration of oral transmucosal dosage forms
0
Patent Primary Examiner
‌
Brian Gulledge
Patent abstract

Formulations for controlled delivery of oral transmucosal medications are provided. The formulations are characterized as hydrogel-forming or eroding-types which are bioadhesive and provide for controlled and sustained release of the medication such that enhanced bioavailability and efficacy is provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8252328 Bioadhesive drug formulations for oral transmucosal delivery

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us